Skip to main content

Table 8 Multivariate logistic regression for the composite effectiveness outcomes (symptomatic/non-symptomatic DVT up to POD10 and PE up to POD28) in patients receiving THA

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Predictors Odds ratio 95% CI P value
Age, 75 years 1.82 1.15-2.87 0.011
Female gender 2.31 1.03-5.18 0.041
e-GFR, <60 mL/min per 1.73 m2 0.81 0.44-1.50 0.502
Body mass index, 30 kg/m2 0.89 0.36-2.20 0.803
General anesthesia 0.41 0.23-0.71 0.002
Operation time, 120 minutes 0.79 0.50-1.23 0.293
Use of foot pump 1.08 0.59-1.96 0.808
Use of elastic stocking 0.51 0.26-1.01 0.052
Medications    
  Unfractionated heparin 1.27 0.44-3.61 0.658
  Enoxaparin 0.84 0.44-1.57 0.577
  Fondaparinux 0.36 0.20-0.66 0.001
  Others 1.36 0.55-3.36 0.502
  1. CI, confidence interval; DVT, deep vein thrombosis; e-GFR, estimated glomerular filtrating ratio; PE, pulmonary embolism; THA, total hip arthroplasty.